Discovery Channel's annual Shark Week celebration returns with a new trailer showcasing premieres like How to Train a Great ...

Apple TV's Maximum Pleasure Guaranteed is a comedy thriller about a woman who connects with a camboy online, only to become the victim of a twisty blackmail scheme. The series also stars Jake Johnson ...

"They mean we're going to have fewer customers, which is troubling. But it may lead to stronger customers, which is good news ...

The cable news channel may not be the ratings juggernaut it once was, but it matters to President Trump, and David Ellison ...

While exploring its natural habitat – the Bermuda Triangle – in 2022, History Channel stumbled across an intriguing piece of material, prompting them to contact NASA for further analysis. Intrigue ...

Anthropic will start a drug discovery program focused on "neglected" diseases. The artificial intelligence company announced the effort alongside the announcement of Claude Science, a product designed ...

Anthropic is launching an internal drug discovery program with a focus on neglected diseases that traditional pharmaceutical companies would not consider commercially attractive, CNBC reported June 30 ...

After scrapping development of its diabetic macular edema treatment avoralstat last month, BioCryst Pharmaceuticals is shuttering all internal discovery programs to focus on external innovation and ...

June 29 (Reuters) - BioCryst Pharmaceuticals (BCRX.O), opens new tab said on Monday it would wind down its internal drug discovery programs and close its Alabama research facility by the end of ‌2026, ...

BioCryst said it would discontinue its internal discovery programs and prioritize external innovation, in an effort to strengthen its rare-disease pipeline. As part of the shift, BioCryst will close ...

WILMINGTON, N.C. (WECT) - Cape Fear Community College (CFCC) will host a Career Discovery Night this month, focusing on the Simulation and Game Development program. According to CFCC, attendees will ...

—Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth— —Completes enrollment in Phase 3 ALPHA-ORBIT for navenibart, ...